Abstract

Cidofovir 0.2-mg/mL Intravitreous Injection

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2009 - Geriatric Compounding

Page(s): 554

Download in electronic PDF format for $75
  • Cidofovir 0.2-mg/mL Intravitreous Injection Page 1

Abstract

A formulation for preparing Cidofovir 0.2-mg/mL Intravitreous Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • cidofovir
  • antiviral agent
  • ophthalmic preparations
  • eye infections
  • cytomegalovirus
  • CMV retinitis
  • intravitreous injection

Related Categories

  • FORMULATIONS
  • OPHTHALMICS
  • DOSAGE FORMS/DRUG CARRIERS
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2009
Pg. 554
Cidofovir 0.2-mg/mL Intravitreous Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 324-328
Topical Cidofovir for Treatment of Resistant Viral Infections
Author(s): McElhiney Linda F
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 336
Foscarnet Sodium 24-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 270-280
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Author(s): Logomasini Mark A, Stout Richard R, Ron Marcinkoski
Mar/Apr 1997
Pg. 132-134
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Zhang Yan-ping, Trissel Lawrence A
Sep/Oct 2007
Pg. 422
Ergonovine Maleate 0.2-mg/mL Injection, Veterinary
Author(s): Allen Loyd V Jr
Nov/Dec 2009
Pg. 506-515
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Sep/Oct 2016
Pg. 399-404
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 159
Glycopyrrolate 0.2-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 301-308
Basics of Sterile Compounding: Excipients Used in Injections
Author(s): Akers Michael J
Jan/Feb 2013
Pg. 69
Milrinone 0.2-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 418-426
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Sep/Oct 2010
Pg. 421
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 481
Valganciclovir Hydrochloride 60-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 131
Cidofovir Suppositories
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 60
Aztreonam Injection
Author(s): Allen Loyd V Jr